President's Cancer Panel

The President's Cancer Panel is a three-person panel that reports to the President of the United States on the development and execution of the National Cancer Program. Members serve 3-year terms, and at least two of the three panel members must be distinguished scientists or physicians. The President appoints one of the members to a one-year Chair position. The Panel meets at least four times each year, and these meetings are open to the public.[1] The Panel was established in 1971 by the National Cancer Act.[2]

As of July 2022, the Panel consists of Elizabeth M. Jaffee, M.D., FACR, FAACP, (Chair), Mitchel S. Berger, M.D., FACS, FAANS, and Carol L. Brown, M.D., FACOG, FACS. [3]

References
  1. "Division of Extramural Activities President's Cancer Panel Charter Summary" (PDF). National Institutes of Health. Retrieved 4 May 2019.
  2. "Overview of National Cancer Act 1971". National Cancer Institute. Archived from the original on September 24, 2015. Retrieved 12 September 2015.
  3. "President's Cancer Panel". Retrieved 7 August 2023.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.